Microbot Medical (NASDAQ:MBOT – Get Free Report) is anticipated to release its earnings data before the market opens on Wednesday, March 26th. Analysts expect Microbot Medical to post earnings of ($0.18) per share for the quarter.
Microbot Medical Price Performance
NASDAQ MBOT opened at $1.70 on Monday. Microbot Medical has a 1-year low of $0.82 and a 1-year high of $3.38. The company has a market cap of $59.06 million, a PE ratio of -2.12 and a beta of 1.60. The stock’s 50 day simple moving average is $1.76 and its 200-day simple moving average is $1.30.
Analysts Set New Price Targets
Separately, HC Wainwright lifted their target price on shares of Microbot Medical from $7.00 to $9.00 and gave the stock a “buy” rating in a research note on Friday, January 24th.
About Microbot Medical
Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces.
Featured Articles
- Five stocks we like better than Microbot Medical
- Should You Invest in Penny Stocks?
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- 3 ETFs to Ride the VIX Surge During Market Volatility
- Ride Out The Recession With These Dividend Kings
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
Receive News & Ratings for Microbot Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbot Medical and related companies with MarketBeat.com's FREE daily email newsletter.
